{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:39:26Z","timestamp":1794267566084,"version":"4.9.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-05543-7","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:17:59Z","timestamp":1751361479000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparative efficacy of clindamycin phosphate with benzoyl peroxide versus clindamycin phosphate with adapalene in acne vulgaris: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"15","author":[{"given":"Ali","family":"Aleid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulsalam Mohammed","family":"Aleid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houriah Yasir","family":"Nukaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajar Ahmed AL","family":"Mustanyir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghadeer Yahya","family":"Almasabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar Mustafa","family":"Alsaeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghad Waheed","family":"Nadra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Alshammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman Hamdan","family":"Alsaqri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kawthar","family":"Alsaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Daniyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas Al","family":"Mutair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"1","key":"5543_CR1","first-page":"15","volume":"85","author":"JQ Del Rosso","year":"2010","unstructured":"Del Rosso, J. Q. & Schmidt, N. F. A review of the anti-inflammatory properties of clindamycin in the treatment of acne vulgaris. Cutis 85 (1), 15\u201324 (2010).","journal-title":"Cutis"},{"issue":"5","key":"5543_CR2","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","volume":"74","author":"AL Zaenglein","year":"2016","unstructured":"Zaenglein, A. L. et al. Guidelines of care for the management of acne vulgaris. J. Am. Acad. Dermatol. 74 (5), 945\u2013973e33 (2016).","journal-title":"J. Am. Acad. Dermatol."},{"key":"5543_CR3","doi-asserted-by":"crossref","unstructured":"Brown, M. T. & Bussell, J. K. Medication adherence: WHO cares? Mayo Clin Proc. ; 86(4):304\u2013314. (2011).","DOI":"10.4065\/mcp.2010.0575"},{"key":"5543_CR4","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.2147\/PPA.S117437","volume":"10","author":"S Moradi Tuchayi","year":"2016","unstructured":"Moradi Tuchayi, S., Alexander, T. M., Nadkarni, A. & Feldman, S. R. Interventions to increase adherence to acne treatment. Patient Prefer Adherence. 10, 2091\u20132096 (2016).","journal-title":"Patient Prefer Adherence"},{"issue":"2","key":"5543_CR5","first-page":"103","volume":"86","author":"BA Yentzer","year":"2010","unstructured":"Yentzer, B. A. et al. Simplifying regimens promotes greater adherence and outcomes with topical acne medications: a randomized controlled trial. Cutis 86 (2), 103\u2013108 (2010).","journal-title":"Cutis"},{"issue":"11","key":"5543_CR6","first-page":"30","volume":"4","author":"LH Kircik","year":"2011","unstructured":"Kircik, L. H. Synergy and its clinical relevance in topical acne therapy. J. Clin. Aesthet. Dermatol. 4 (11), 30\u201333 (2011).","journal-title":"J. Clin. Aesthet. Dermatol."},{"issue":"8","key":"5543_CR7","first-page":"475","volume":"100","author":"LK Oge\u2019","year":"2019","unstructured":"Oge\u2019, L. K., Broussard, A. & Marshall, M. D. Acne vulgaris: diagnosis and treatment. Am. Fam Physician. 100 (8), 475\u2013484 (2019).","journal-title":"Am. Fam Physician"},{"issue":"1","key":"5543_CR8","doi-asserted-by":"publisher","first-page":"15029","DOI":"10.1038\/nrdp.2015.29","volume":"1","author":"SM Tuchayi","year":"2015","unstructured":"Tuchayi, S. M. et al. Acne vulgaris. Nat. Rev. Dis. Primer. 1 (1), 15029 (2015).","journal-title":"Nat. Rev. Dis. Primer"},{"issue":"5","key":"5543_CR9","doi-asserted-by":"publisher","first-page":"515","DOI":"10.4103\/0019-5154.190102","volume":"61","author":"N Hazarika","year":"2016","unstructured":"Hazarika, N. & Archana, M. The psychosocial impact of acne vulgaris. Indian J. Dermatol. 61 (5), 515\u2013520 (2016).","journal-title":"Indian J. Dermatol."},{"issue":"6","key":"5543_CR10","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1590\/S0365-05962012000600007","volume":"87","author":"E Tasoula","year":"2012","unstructured":"Tasoula, E. et al. The impact of acne vulgaris on quality of life and psychic health in young adolescents in greece. Results of a population survey. Bras. Dermatol. 87 (6), 862\u2013869 (2012).","journal-title":"Bras. Dermatol."},{"key":"5543_CR11","doi-asserted-by":"crossref","unstructured":"Armillei, M. K., Lomakin, I. B., Del Rosso, J. Q., Grada, A. & Bunick, C. G. Scientific rationale and clinical basis for clindamycin use in the treatment of dermatologic disease. Antibiot. Basel ; 17; 13(3). (2024).","DOI":"10.3390\/antibiotics13030270"},{"issue":"7","key":"5543_CR12","first-page":"25","volume":"5","author":"VD Callender","year":"2012","unstructured":"Callender, V. D., Young, C. M., Kindred, C. & Taylor, S. C. Efficacy and safety of clindamycin phosphate 1.2% and tretinoin 0.025% gel for the treatment of acne and acne-induced Post-inflammatory hyperpigmentation in patients with skin of color. J. Clin. Aesthet. Dermatol. 5 (7), 25\u201332 (2012).","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"5543_CR13","doi-asserted-by":"crossref","unstructured":"Vashisth, M. et al. Antibiotics targeting bacterial protein synthesis reduce the lytic activity of bacteriophages. Virus Res [Internet]. ; Available from: Nov;321:198909. (2022).","DOI":"10.1016\/j.virusres.2022.198909"},{"key":"5543_CR14","unstructured":"Fakhouri, T., Yentzer, B. A. & Feldman, S. Advancement in benzoyl peroxide-based acne treatment: methods to increase both efficacy and tolerability. J. Drugs Dermatol. Jul 8. (2009)."},{"issue":"3","key":"5543_CR15","first-page":"CD011154","volume":"16","author":"Z Yang","year":"2020","unstructured":"Yang, Z. et al. Topical benzoyl peroxide for acne. Cochrane Database Syst. Rev. 16 (3), CD011154 (2020).","journal-title":"Cochrane Database Syst. Rev."},{"key":"5543_CR16","unstructured":"Patel, M., Bowe, W. P., Heughebaert, C. & Shalita, A. R. The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review. J. Drugs Dermatol. Jun 9. (2010)."},{"key":"5543_CR17","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.2147\/TCRM.S94062","volume":"12","author":"SY Kim","year":"2016","unstructured":"Kim, S. Y. & Ochsendorf, F. R. New developments in acne treatment: role of combination adapalene-benzoylperoxide. Ther. Clin. Risk Manag. 12, 1497\u20131506 (2016).","journal-title":"Ther. Clin. Risk Manag"},{"issue":"1","key":"5543_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/120347540100500109","volume":"5","author":"JJ Leyden","year":"2001","unstructured":"Leyden, J. J., Hickman, J. G., Jarratt, M. T., Stewart, D. M. & Levy, S. F. The efficacy and safety of a combination benzoyl peroxide\/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide\/erythromycin combination product. J. Cutan. Med. Surg. 5 (1), 37\u201342 (2001).","journal-title":"J. Cutan. Med. Surg."},{"key":"5543_CR19","unstructured":"US Food and Drug Administration. Drugs@FDA: FDA-approved drugs. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=016921. Accessed 9 Jul 2022."},{"issue":"2","key":"5543_CR20","first-page":"165","volume":"67","author":"EH Tschen","year":"2001","unstructured":"Tschen, E. H. et al. A combination benzoyl peroxide and clindamycin topical gel compared with benzoyl peroxide, clindamycin phosphate, and vehicle in the treatment of acne vulgaris. Cutis 67 (2), 165\u2013169 (2001).","journal-title":"Cutis"},{"issue":"2","key":"5543_CR21","first-page":"110","volume":"84","author":"LS Gold","year":"2009","unstructured":"Gold, L. S. et al. A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne. Cutis 84 (2), 110\u2013116 (2009).","journal-title":"Cutis"},{"issue":"3","key":"5543_CR22","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/bjd.20080","volume":"185","author":"B Stuart","year":"2021","unstructured":"Stuart, B. et al. Topical preparations for the treatment of mild-to-moderate acne vulgaris: systematic review and network meta-analysis. Br. J. Dermatol. 185 (3), 512\u2013525 (2021).","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"5543_CR23","first-page":"160","volume":"5","author":"JQ Del Rosso","year":"2006","unstructured":"Del Rosso, J. Q. & Tanghetti, E. The clinical impact of vehicle technology using a patented formulation of benzoyl peroxide 5%\/clindamycin 1% gel: comparative assessments of skin tolerability and evaluation of combination use with a topical retinoid. J. Drugs Dermatol. 5 (2), 160\u2013164 (2006).","journal-title":"J. Drugs Dermatol."},{"issue":"4","key":"5543_CR24","first-page":"621","volume":"Aug;3","author":"S Piskin","year":"2007","unstructured":"Piskin, S. & Uzunali, E. A review of the use of adapalene for the treatment of acne vulgaris. Ther. Clin. Risk Manag. Aug;3 (4), 621\u2013624 (2007).","journal-title":"Ther. Clin. Risk Manag"},{"key":"5543_CR25","doi-asserted-by":"crossref","unstructured":"Rusu, A., Tanase, C., Pascu, G. A. & Todoran, N. Recent advances regarding the therapeutic potential of adapalene. Pharm. Basel Aug 28. (2020).","DOI":"10.3390\/ph13090217"},{"key":"5543_CR26","unstructured":"Tolaymat, L., Dearborn, H., Adapalene, Z. P. M. & StatPearls Treasure Island (FL: StatPearls Publishing); (2024)."},{"key":"5543_CR27","first-page":"7992","volume":"4","author":"AN Feneran","year":"2011","unstructured":"Feneran, A. N., Kaufman, W. S., Dabade, T. S. & Feldman, S. Retinoid plus antimicrobial combination treatments for acne. Clin. Cosmet. Investig Dermatol. 4, 7992 (2011).","journal-title":"Clin. Cosmet. Investig Dermatol."},{"issue":"1","key":"5543_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s40257-021-00650-3","volume":"23","author":"L Stein Gold","year":"2022","unstructured":"Stein Gold, L. et al. Efficacy and safety of a Fixed-Dose clindamycin phosphate 1.2%, benzoyl peroxide 3.1%, and adapalene 0.15% gel for Moderate-to-Severe acne: A randomized phase II study of the first Triple-Combination drug. Am. J. Clin. Dermatol. 23 (1), 93\u2013104 (2022).","journal-title":"Am. J. Clin. Dermatol."},{"issue":"4","key":"5543_CR29","first-page":"s148","volume":"18","author":"LH Kircik","year":"2019","unstructured":"Kircik, L. H., Draelos, Z. D. & Berson, D. S. Polymeric emulsion technology applied to tretinoin. J. Drugs Dermatol. 18 (4), s148\u2013s154 (2019).","journal-title":"J. Drugs Dermatol."},{"issue":"2 Pt 3","key":"5543_CR30","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/S0190-9622(98)70440-2","volume":"39","author":"B Shroot","year":"1998","unstructured":"Shroot, B. Pharmacodynamics and pharmacokinetics of topical adapalene. J. Am. Acad. Dermatol. 39 (2 Pt 3), S17\u201324 (1998).","journal-title":"J. Am. Acad. Dermatol."},{"key":"5543_CR31","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton, B. et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann. Intern. Med. 162, 777\u2013784 (2015).","journal-title":"Ann. Intern. Med."},{"key":"5543_CR32","unstructured":"Page, M. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ Mar 29. (2021)."},{"key":"5543_CR33","doi-asserted-by":"crossref","unstructured":"Sterne Gold, J. A. C. et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ (2019).","DOI":"10.1136\/bmj.l4898"},{"issue":"3","key":"5543_CR34","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/pde.15283","volume":"22","author":"LF Eichenfield","year":"2023","unstructured":"Eichenfield, L. F. et al. Triple-combination clindamycin phosphate 1.2%\/benzoyl peroxide 3.1%\/adapalene 0.15% gel for moderate-to-severe acne in children and adolescents: randomized phase 2 study. Pediatr. Dermatol. 22 (3), 452\u2013459 (2023).","journal-title":"Pediatr. Dermatol."},{"issue":"8","key":"5543_CR35","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/1346-8138.14497","volume":"45","author":"N Hayashi","year":"2018","unstructured":"Hayashi, N. et al. Clindamycin phosphate 1.2%\/benzoyl peroxide 3% fixed-dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, investigator-blind, parallel-group study. J. Dermatol. 45 (8), 951\u2013962 (2018).","journal-title":"J. Dermatol."},{"issue":"8","key":"5543_CR36","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00403-024-03346-w","volume":"316","author":"JA Sesgundo","year":"2024","unstructured":"Sesgundo, J. A. et al. Comparative efficacy and safety of clindamycin phosphate\/benzoyl peroxide and adapalene\/benzoyl peroxide in acne treatment: a systematic review and meta-analysis of randomized controlled trials. Arch. Dermatol. Res. 316 (8), 595 (2024).","journal-title":"Arch. Dermatol. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05543-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05543-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05543-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T00:09:00Z","timestamp":1757203740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05543-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5543"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-05543-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: The original version of this Article omitted an affiliation for Abbas Al Mutair. The correct affiliations are listed here. Almoosa College of Health Sciences, Al-Hasa, Saudi Arabia. University of Wollongong, Wollongong, Australia. Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia. Prince Sultan Military College of Health Sciences, Dhahran, Saudi Arabia. Research Center, Almoosa Specialist Hospital, Al-Ahsa, Saudi Arabia. The original Article has been corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20478"}}